Firebrick Presents at Healthcare Investor Conference
COVID-19_arXiv on X: "Title: In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays. Authors: Simon P Tucker, Stephen... https://t.co